Registration for the conference is now open, click here.
|Full Delegate||Thursday Only||Friday Only||Saturday Only|
*Early Bird Prices
EARLY BIRD DEADLINE: 10th July 2017
If you submitted an Abstract for Brighton Sleep 2017 you will be eligible for the following prizes:
Best Paediatric Poster
Best Clinical Poster
Best Research Poster
7 Green Ribbons
BSS/ ARTP Lyn Davis Award 2018
BSS Early Years Investigator Award
The Colin Sullivan Award is for young Investigators starting their research and clinical Career.
Colin Sullivan Research Award - Application Guidance
Brighton Sleep 2017 will be the largest multi-disciplinary UK meeting dedicated to sleep medicine and research. With a range of superb speakers, it is an event not to be missed!
Thursday 12th October 2017
Friday 13th October 2017
Saturday 14th October 2017
ResMed (NYSE:RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 2 million patients remotely monitored every day.
Our 5,000-strong team is committed to creating the world's best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries.
Bioprojet PharmaBioprojet PharmaLincoln Medical Limited
● A Privately-owned pharmaceutical company, with basic research at its heart
● Created in 1982 by Dr. Jeanne-Marie Lecomte and Prof. Jean-Charles Schwartz
● Activities are centred upon the design and development of novel drugs, achieved through collaboration with academic laboratories and other companies
● In the Mid-1970s, Prof. Schwartz discovered that histamine should be added to the growing list of novel cerebral transmitters, with a traditional pharmacological approach in 1983 revealing the third histamine receptor
● The same in vitro test was used to design, in 1987, the first highly selective and potent H3-autoreceptor ligands, establishing the main function of cerebral histaminergic neurons, namely their role in maintenance of wakefulness, attention and learning and other cognitive processes
● In 1990, the cloning of the gene of the H3-receptor facilitated the development of H3-receptor inverse agonist programs in many drug companies
● Bioprojet PHARMA’s strategy has resulted so far in the development of a number of first-in-class compounds, including WAKIX (pitolisant) for the treatment of adults with narcolepsy with or without cataplexy
● Founded in June 2000 by a group of pharmaceutical industry executives with the aim of delivering life-saving medicines
● Acquired by Bioprojet PHARMA in 2004, Lincoln Medical Limited is the UK and Ireland distributor for WAKIX (pitolitsant)
Activinsights deliver patient lifestyle insight to medical practitioners, researchers and healthcare providers using accurate wearables. We build objective, lifestyle reports which provide invaluable information for both patients and professionals when planning effective interventions. Our technologies and data analysis approaches are supported by over 100 peerreviewed scientific papers, in over 40 countries worldwide. Activinsights has a unique heritage through our support of health researchers and sports scientists with measurement equipment. This experience has built our knowledge base, validated our products and developed new data analysis tools.
Advanced Medical Equipment Ltd. is a British company based in Horsham, West Sussex. Founded in 2002, it specialises in the distribution of technology, providing equipment, services and consumables for medical, clinical and research use, mainly in the Neurology field. We distribute among other world leading companies, Compumedics from Melbourne Australia. Compumedics designs and manufactures innovative technologies for the diagnosis of sleep disorders. We have a comprehensive range of products for clinical and research purposes. We are actively involved in sleep science globally and have the best in class sleep amplifier and analytics technologies. Since 1987, Compumedics’ strategy has focused on developing its core competency – Sleep Diagnostics – which has enabled the company to become one of the leaders in this growing international healthcare market. Today, Compumedics has evolved into one of the world’s leading suppliers of medical technology for sleep and neuro diagnostics (including brain research).
The Association for Respiratory Technology & Physiology (ARTP), through standards of training and quality assurance, are the professional guardians of physiological measurement issues in respiratory medicine in the UK. With over 35 years of experience in the design and delivery of lung function services, ARTP provides the only national, professionally recognised, qualifications in Respiratory Function Testing and Spirometry in the UK. ARTP also recommends standards for the design and delivery of lung function services through position papers from ARTP Working Groups on the structure, function and content of lung function facilities in the UK. An important function of the ARTP is the provision of opportunities for Continuing Professional Development. The ARTP organises meetings and courses on many respiratory topics. Nationally ARTP informs and influences major organisations about the delivery of lung function services. Furthermore, ARTP links with equivalent national organisations around the world to deliver global standards in respiratory healthcare involving respiratory technology and physiology.
Baywater Healthcare is a leading specialist provider of home oxygen and healthcare services to more than 30,000 patients with long term conditions.
Our services reflect the needs of our patients and commissioners with care closer to the home and efficiency savings.
Please call us on 0845 6020776.
CamNtech has over 20 years of experience with wearable technology for sleep monitoring. The MotionWatch is one of the smallest, lightest Actigraphy devices currently available with recording for up to 120 days. Manufactured to the highest standards in our ISO13485 facility, our products are CE marked, FDA cleared medical devices.
Dolby Vivisol is a unique UK provider of Home Healthcare services specialising in respiratory care. They offer a range of services including home oxygen therapy; of which they currently hold three of the NHS regional contracts including over 20,000 patients. Dolby Vivisol offers a range of other services including ventilation, diagnostics and treatment of sleep disordered breathing and nebuliser therapy of which they provide to over 300,000 patients across Europe today. Through their extensive experience throughout the UK and Europe supporting research and innovation, they successfully provide patients with an exceptional level of care which ultimately improves their quality of life.
Drive DeVilbiss Healthcare are one the world’s leading, manufacturers and distributors of durable medical products. DeVilbiss Healthcare and a number of other healthcare companies were acquired by Drive Medical in 2015. At the start of 2017 the integration was completed and in the UK we are now operating as one single entity – Drive DeVilbiss Healthcare. You know us as providers of oxygen, sleep and respiratory therapy but we are also specialists in a number of other segments, homecare, daily-living aids, mobility and pressure prevention to name just a few. Our ultimate aim is to support our customers and users now and for the road ahead. Whilst you are in Brighton visit us to view the our DeVilbiss Blue CPAP series and our ever popular SleepCube series! Our expert staff will be hand to answer any questions that you may have, as well as providing advice and product demonstrations.
At Flynn Pharma, we aim to rediscover tried and trusted branded pharmaceutical products. We re-energise products for underserved patient populations through effective, ongoing supply chain management, targeted promotion, and product development programmes that focus on improving formulations and introducing new indications.
GDS Medtech have a long standing reputation within the medical sector as a supplier of product solutions for sleep and snoring. We work with manufacturers from around the world and are delighted to bring our portfolio of innovative, evidence based products to Brighton Sleep 2017. We look forward to welcoming you to our stand.
Intus Healthcare has been helping people with Sleep Disordered Breathing (SDB) for many years, supported by an extensive portfolio of e-commerce and educational websites. Intus cater for both private-paying individuals across Europe and supply numerous NHS Hospitals and sleep clinics with equipment throughout the UK. They primarily provide CPAP (Continuous Positive Airway Pressure) equipment, with one of the largest product ranges available in Europe. Intus have also recently launched a new Sleep Apnoea sleep study reporting service using the innovative BresoDx diagnostic, details of which can be found on the brochure inside your delegate bag.
Itamar Medical Ltd. is a publicly traded medical device company (TASE:ITMR) based in Israel that develops non-invasive medical devices using the proprietary PAT™ (Peripheral Arterial Tone) signal. Since its founding in 1997, the Company has engaged in research and development of non-invasive medical devices for diagnosis of various medical conditions, including cardiovascular disease and respiratory disorders. WatchPAT™ An innovative FDA-cleared device for the diagnosis of sleep breathing disorders, specifically Sleep Apnea. It is a small wrist mounted device which allows testing in the comfort of the patient’s own home.
Nihon Kohden is Japan’s largest medical device company renowned the world over for innovation, reliability and engineering quality, we have been manufacturing medical devices for more than 60 years. Supplying hospitals around the world with advanced medical equipment our product range focuses on patient monitoring, cardiology (ECG equipment and defibrillators) as well as neurology (EEG, EMG and EP) and sleep study. Please come along to our stand to see the new 'Life Scope G3' a wearable vital sign monitor designed to use hospital Wi-Fi for mobile monitoring of patients throughout the hospital. Life Scope G3 monitors ECG, Respiration and SpO2 to support phases of patient care such as transportation or rehabilitation.
Philips, a global leader in the sleep and respiratory markets, is passionate about improving the quality of people's lives with solutions designed around the needs of our customers and their patients. Innovation is driven by gaining insight into the needs of the people who use our products for sleep management, oxygen therapy, noninvasive ventilation and respiratory drug delivery.
The Registration Council for Clinical Physiologists (RCCP) was established in 2001 and maintains a voluntary register for clinical physiologists in the UK practicing in the six disciplines of clinical physiology: respiratory physiology, audiology (including hearing therapists), cardiology, gastrointestinal physiology, neurophysiology , and sleep physiology. Our key aim is to ensure the highest levels of safety for patients of clinical physiologists. We exist because the profession is not regulated by the government, which means that clinical physiologists are not regulated and monitored in the same way as doctors and nurses and they cannot be sanctioned in the same way if mistakes occur. We ensure high standards in clinical physiology by ensuring that registrants continually abide by our code of conduct and standards for the protection of the public. A clinician who is on RCCP Register has volunteered to be regulated by RCCP and their registration comes with an assurance that they have the highest standards of education and training and that no serious concerns have been raised with us about their work.
S4S is an established and innovative dental laboratory that provides dental splint technology and orthodontic solutions for over 6000 clients. Established in 2005 on a strong clinical background, we were originally known as Solutions for Snoring, an area that remains at the heart of what we do.
As the exclusive providers of the self-adjusting Sleepwell - the most clinically-proven MAS for snoring and mild to moderate sleep apnoea (Barnes et al, 2004) - we have a focus on continuous improvement, and have recently worked with the University of Sheffield’s Advanced Manufacturing Research Centre to further develop the splint, and offer a new injection moulding technique for accuracy and strength.
Based in Sheffield, we deliver a first-class local service to our clients throughout the UK.
For more information of S4S and their team, visit s4sdental.com.
SomnoMed provides treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent® becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea (OSA). More than 300,000 patients around the world have treated their mild to moderate obstructive sleep apnea (OSA) with SomnoDent oral device therapy. Worn during sleep and fitted by a dental sleep specialist, the SomnoDent line of oral appliances are customized to offer superior comfort and quality to each individual patient.
Stowood Scientific Instruments are the authors and suppliers of Visi-Download, which is the ‘gold standard’ software for downloading many manufacturers’ oximeters and capnometers (including Masimo, Konica Minolta, Bitmos, GE (Ohmeda) Radiometer, BCI). Designers and manufacturers of the Visi sleep system and the Grey Flash and Black Shadow sleep screeners. Designers and manufacturers of the OSLER test, a behavioural alternative to the Multiple Wakefulness Test. Distributors of the Konica Minolta wristwatch oximeters.
Distributors of the full range of Natus Embletta and Embla sleep systems. Originators of the Hoxam database for managing oxygen in the home. Stowood’s ethos is to prioritize customers’ technical requirements over fast sales. We celebrated our 25th anniversary in September 2017 and are proud to continue working with the UK’s sleep experts.
UCB is a global biopharmaceutical company, with a focus on neurology and immunology.
UCB’s ambition is to transform the lives of people living with severe diseases. We focus on neurology and immunology disorders – putting patients at the center of our world. We are Inspired by Patients. Driven by Science. We listen. Our medicines treat thousands of people around the world and we are engaging with patients, their families and healthcare professionals to address their unmet needs. We want to enhance our understanding of disease and the real-life experiences of patients so that our teams are able to deliver the right drug and the right care to the right patient. UCB is continuously working to advance science and embrace new knowledge. We are leveraging scientific advances and skills in areas such as genetics, biomarkers and human biology. Patients inspire us to bring them value through cutting-edge science, innovative drugs, and practical solutions – so that they and their carers can get on with their lives. We recognise that radical changes are taking place in the eco-system of care and that we need to evolve accordingly to deliver on our vision. The key element of our evolution is to focus on the delivery of increased patient value. There is no such thing as an “average patient”. We want to use all the tools, channels and scientific advances at our disposal to develop a better understanding of the various expressions of a disease and embed the real needs of specific patient populations in our science and innovation process. That is why we support patient groups who provide valuable services to patient communities and understand what matters to people living with severe diseases. We believe in partnership. Our scientists collaborate with leading researchers from academia and industry to advance science and deliver the solutions patients need. Our open approach to innovation equips us to meet today’s biggest healthcare challenges.